Report of joint hypermobility in malignant hyperthermia susceptible patients: Observational study with a case-control descriptive design

Background: Hypermobility is the capacity to perform joint movements in amplitudes greater than normal. Hypermobility is present in nearly 100 % of congenital myopathy central core disease (CCD) patients but is sporadically described in the allelic disease malignant hyperthermia (MH). Our objective...

Full description

Saved in:
Bibliographic Details
Main Authors: Rita CCS. Santos, Larissa FCDMS. Lima, Pâmela V. Andrade, Joilson M. Santos, Leonardo Galleni, Antonio FR. Junior, Lucas S. Souza, Beny Schmidt, Acary SB. Oliveira, José LG. Amaral, Mariz Vainzof, Helga CA. Silva
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844025001562
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832573146118488064
author Rita CCS. Santos
Larissa FCDMS. Lima
Pâmela V. Andrade
Joilson M. Santos
Leonardo Galleni
Antonio FR. Junior
Lucas S. Souza
Beny Schmidt
Acary SB. Oliveira
José LG. Amaral
Mariz Vainzof
Helga CA. Silva
author_facet Rita CCS. Santos
Larissa FCDMS. Lima
Pâmela V. Andrade
Joilson M. Santos
Leonardo Galleni
Antonio FR. Junior
Lucas S. Souza
Beny Schmidt
Acary SB. Oliveira
José LG. Amaral
Mariz Vainzof
Helga CA. Silva
author_sort Rita CCS. Santos
collection DOAJ
description Background: Hypermobility is the capacity to perform joint movements in amplitudes greater than normal. Hypermobility is present in nearly 100 % of congenital myopathy central core disease (CCD) patients but is sporadically described in the allelic disease malignant hyperthermia (MH). Our objective was to investigate the frequency/characteristics of hypermobility in MH susceptible patients as compared to a control group, aiming the identification of correlations between hypermobility and demographic/clinical findings in MH patients. Methods: We recruited 26 MH patients (MH history, positive in vitro contracture test (IVCT), no muscle weakness, no cores in muscle biopsy) and 23 controls (no MH/myopathy history). Patients/medical records were evaluated for obtaining demographic/clinical data. Hypermobility was assessed in all patients and controls with Bulbena score. Goniometry was performed in a subset of 11 patients and 11 controls. Results: Bulbena score indicative of hypermobility was significantly more frequent in MH than in the control group (50 % versus 13 %, relative risk 2.06 (95%CI 1.27–3.35), chi-square test, p < .01). Goniometric assessment revealed significantly greater range of motion of mostly proximal movements in MH versus control groups. In the MH group, there was no correlation of the Bulbena score with age, sex, clinical complaints of myalgia/cramps, CK levels, IVCT result, or degree of contracture after caffeine or halothane. Conclusions: It is possible that predominantly proximal hypermobility is part of a clinical spectrum associated with RYR1 gene variants, as it was present even when associated muscle weakness was not present. More studies are necessary to measure evolution and long-term impact of hypermobility in MH patients.
format Article
id doaj-art-59e6c77a57bb471fbb3cc7923d8e0c82
institution Kabale University
issn 2405-8440
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj-art-59e6c77a57bb471fbb3cc7923d8e0c822025-02-02T05:28:09ZengElsevierHeliyon2405-84402025-01-01112e41776Report of joint hypermobility in malignant hyperthermia susceptible patients: Observational study with a case-control descriptive designRita CCS. Santos0Larissa FCDMS. Lima1Pâmela V. Andrade2Joilson M. Santos3Leonardo Galleni4Antonio FR. Junior5Lucas S. Souza6Beny Schmidt7Acary SB. Oliveira8José LG. Amaral9Mariz Vainzof10Helga CA. Silva11MH Diagnosis and Investigation Study Centre (CEDHIMA: Centro de Estudo, Diagnóstico e Investigação de Hipertermia Maligna) - Anesthesiology, Pain and Intensive Therapy Department - Universidade Federal de São Paulo, São Paulo, SP, BrazilMH Diagnosis and Investigation Study Centre (CEDHIMA: Centro de Estudo, Diagnóstico e Investigação de Hipertermia Maligna) - Anesthesiology, Pain and Intensive Therapy Department - Universidade Federal de São Paulo, São Paulo, SP, BrazilMH Diagnosis and Investigation Study Centre (CEDHIMA: Centro de Estudo, Diagnóstico e Investigação de Hipertermia Maligna) - Anesthesiology, Pain and Intensive Therapy Department - Universidade Federal de São Paulo, São Paulo, SP, BrazilMH Diagnosis and Investigation Study Centre (CEDHIMA: Centro de Estudo, Diagnóstico e Investigação de Hipertermia Maligna) - Anesthesiology, Pain and Intensive Therapy Department - Universidade Federal de São Paulo, São Paulo, SP, BrazilBioscience Institute, Human Genome and Stem Cells Research Center - University of São Paulo, São Paulo, SP, BrazilBioscience Institute, Human Genome and Stem Cells Research Center - University of São Paulo, São Paulo, SP, BrazilBioscience Institute, Human Genome and Stem Cells Research Center - University of São Paulo, São Paulo, SP, BrazilDepartment of Pathology, Universidade Federal de São Paulo, São Paulo, SP, BrazilDepartment of Neurology, Universidade Federal de São Paulo, São Paulo, SP, BrazilMH Diagnosis and Investigation Study Centre (CEDHIMA: Centro de Estudo, Diagnóstico e Investigação de Hipertermia Maligna) - Anesthesiology, Pain and Intensive Therapy Department - Universidade Federal de São Paulo, São Paulo, SP, BrazilBioscience Institute, Human Genome and Stem Cells Research Center - University of São Paulo, São Paulo, SP, BrazilMH Diagnosis and Investigation Study Centre (CEDHIMA: Centro de Estudo, Diagnóstico e Investigação de Hipertermia Maligna) - Anesthesiology, Pain and Intensive Therapy Department - Universidade Federal de São Paulo, São Paulo, SP, Brazil; Corresponding author. Brazilian Malignant Hyperthermia Center. University Federal São Paulo, Rua Pedro Toledo, 781, SP, 04039-032, Brazil.Background: Hypermobility is the capacity to perform joint movements in amplitudes greater than normal. Hypermobility is present in nearly 100 % of congenital myopathy central core disease (CCD) patients but is sporadically described in the allelic disease malignant hyperthermia (MH). Our objective was to investigate the frequency/characteristics of hypermobility in MH susceptible patients as compared to a control group, aiming the identification of correlations between hypermobility and demographic/clinical findings in MH patients. Methods: We recruited 26 MH patients (MH history, positive in vitro contracture test (IVCT), no muscle weakness, no cores in muscle biopsy) and 23 controls (no MH/myopathy history). Patients/medical records were evaluated for obtaining demographic/clinical data. Hypermobility was assessed in all patients and controls with Bulbena score. Goniometry was performed in a subset of 11 patients and 11 controls. Results: Bulbena score indicative of hypermobility was significantly more frequent in MH than in the control group (50 % versus 13 %, relative risk 2.06 (95%CI 1.27–3.35), chi-square test, p < .01). Goniometric assessment revealed significantly greater range of motion of mostly proximal movements in MH versus control groups. In the MH group, there was no correlation of the Bulbena score with age, sex, clinical complaints of myalgia/cramps, CK levels, IVCT result, or degree of contracture after caffeine or halothane. Conclusions: It is possible that predominantly proximal hypermobility is part of a clinical spectrum associated with RYR1 gene variants, as it was present even when associated muscle weakness was not present. More studies are necessary to measure evolution and long-term impact of hypermobility in MH patients.http://www.sciencedirect.com/science/article/pii/S2405844025001562Central core diseaseGoniometryJoint instabilityMalignant hyperthermiaMyopathyRyanodine receptor gene
spellingShingle Rita CCS. Santos
Larissa FCDMS. Lima
Pâmela V. Andrade
Joilson M. Santos
Leonardo Galleni
Antonio FR. Junior
Lucas S. Souza
Beny Schmidt
Acary SB. Oliveira
José LG. Amaral
Mariz Vainzof
Helga CA. Silva
Report of joint hypermobility in malignant hyperthermia susceptible patients: Observational study with a case-control descriptive design
Heliyon
Central core disease
Goniometry
Joint instability
Malignant hyperthermia
Myopathy
Ryanodine receptor gene
title Report of joint hypermobility in malignant hyperthermia susceptible patients: Observational study with a case-control descriptive design
title_full Report of joint hypermobility in malignant hyperthermia susceptible patients: Observational study with a case-control descriptive design
title_fullStr Report of joint hypermobility in malignant hyperthermia susceptible patients: Observational study with a case-control descriptive design
title_full_unstemmed Report of joint hypermobility in malignant hyperthermia susceptible patients: Observational study with a case-control descriptive design
title_short Report of joint hypermobility in malignant hyperthermia susceptible patients: Observational study with a case-control descriptive design
title_sort report of joint hypermobility in malignant hyperthermia susceptible patients observational study with a case control descriptive design
topic Central core disease
Goniometry
Joint instability
Malignant hyperthermia
Myopathy
Ryanodine receptor gene
url http://www.sciencedirect.com/science/article/pii/S2405844025001562
work_keys_str_mv AT ritaccssantos reportofjointhypermobilityinmalignanthyperthermiasusceptiblepatientsobservationalstudywithacasecontroldescriptivedesign
AT larissafcdmslima reportofjointhypermobilityinmalignanthyperthermiasusceptiblepatientsobservationalstudywithacasecontroldescriptivedesign
AT pamelavandrade reportofjointhypermobilityinmalignanthyperthermiasusceptiblepatientsobservationalstudywithacasecontroldescriptivedesign
AT joilsonmsantos reportofjointhypermobilityinmalignanthyperthermiasusceptiblepatientsobservationalstudywithacasecontroldescriptivedesign
AT leonardogalleni reportofjointhypermobilityinmalignanthyperthermiasusceptiblepatientsobservationalstudywithacasecontroldescriptivedesign
AT antoniofrjunior reportofjointhypermobilityinmalignanthyperthermiasusceptiblepatientsobservationalstudywithacasecontroldescriptivedesign
AT lucasssouza reportofjointhypermobilityinmalignanthyperthermiasusceptiblepatientsobservationalstudywithacasecontroldescriptivedesign
AT benyschmidt reportofjointhypermobilityinmalignanthyperthermiasusceptiblepatientsobservationalstudywithacasecontroldescriptivedesign
AT acarysboliveira reportofjointhypermobilityinmalignanthyperthermiasusceptiblepatientsobservationalstudywithacasecontroldescriptivedesign
AT joselgamaral reportofjointhypermobilityinmalignanthyperthermiasusceptiblepatientsobservationalstudywithacasecontroldescriptivedesign
AT marizvainzof reportofjointhypermobilityinmalignanthyperthermiasusceptiblepatientsobservationalstudywithacasecontroldescriptivedesign
AT helgacasilva reportofjointhypermobilityinmalignanthyperthermiasusceptiblepatientsobservationalstudywithacasecontroldescriptivedesign